UpdatesPress Release
NATCO Pharma's Visakhapatnam FDF unit completed a US FDA inspection, receiving a Form 483 with 4 observations.
Natco Pharma LimitedNATCOPHARM · Filed with the exchange
The company believes these are procedural and is confident in addressing them, indicating minimal impact.
No comments yet. Be the first.